GlassScriptPrepare for your visit
Susannah Dintzis
Family · Peoria, IL · NPI 1902848153
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,730.13
in general payments reported to CMS, 2019-2025 · $556 in 2025
The $556 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $348.38
- Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $220.26
- Pfizer INC. $161.12
- Otsuka America Pharmaceutical, INC. $134.99
- Abbott Laboratories $114.96
- Gilead Sciences, INC. $95.48
Drugs and devices associated with these payments
Vraylar Caplyta Comirnaty Prevnar 20 Abrysvo Freestyle Libre 3 Rexulti Rotateq Gardasil 9 Vaxneuvance Vaxelis Sublocade
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Susannah Dintzis listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10727355/susannah-dintzis